[Langerhans'cell histiocytosis: therapeutic approach]

Arch Pediatr. 2008 Jun;15(5):529-31. doi: 10.1016/S0929-693X(08)71822-0.

[Article in French]

Authors

C Thomas¹, J Donadieu

Affiliation

¹ Service d'oncologie pédiatrique, Hôpital Mère enfants, Centre de référence de l'histiocytose, CHU de Nantes, quai Moncousu, 44093 Nantes cedex 03. caroline.thomas@chu-nantes.fr <caroline.thomas@chu-nantes.fr>

PMID: 18582661
DOI: 10.1016/S0929-693X(08)71822-0

No abstract available

MeSH terms

Central Nervous System Diseases / therapy
Child
Histiocytosis, Langerhans-Cell / classification
Histiocytosis, Langerhans-Cell / therapy*
Humans
Nervous System Diseases / etiology
Nervous System Diseases / therapy
Prognosis
Vasopressins / therapeutic use

Substances

Vasopressins